Tianda Pharmaceuticals Statistics

Total Valuation

HKG:0455 has a market cap or net worth of HKD 322.51 million. The enterprise value is 357.95 million.

Market Cap	322.51M
Enterprise Value	357.95M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	Jun 13, 2024

Share Statistics

HKG:0455 has 2.15 billion shares outstanding.

Current Share Class	2.15B
Shares Outstanding	2.15B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	56.72%
Owned by Institutions (%)	n/a
Float	442.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.98
PB Ratio	0.64
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.83
EV / Sales	1.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.81

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.25.

Current Ratio	0.86
Quick Ratio	0.69
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	-4.21
Interest Coverage	-11.16

Financial Efficiency

Return on equity (ROE) is -11.19% and return on invested capital (ROIC) is -5.06%.

Return on Equity (ROE)	-11.19%
Return on Assets (ROA)	-4.02%
Return on Invested Capital (ROIC)	-5.06%
Return on Capital Employed (ROCE)	-10.53%
Revenue Per Employee	470,666
Profits Per Employee	-87,548
Employee Count	701
Asset Turnover	0.39
Inventory Turnover	3.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.02% in the last 52 weeks. The beta is -0.12, so HKG:0455's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-38.02%
50-Day Moving Average	0.16
200-Day Moving Average	0.19
Relative Strength Index (RSI)	46.48
Average Volume (20 Days)	62,700

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:0455 had revenue of HKD 329.94 million and -61.37 million in losses. Loss per share was -0.03.

Revenue	329.94M
Gross Profit	152.02M
Operating Income	-54.15M
Pretax Income	-54.34M
Net Income	-61.37M
EBITDA	-24.47M
EBIT	-54.15M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 91.83 million in cash and 127.45 million in debt, giving a net cash position of -35.61 million or -0.02 per share.

Cash & Cash Equivalents	91.83M
Total Debt	127.45M
Net Cash	-35.61M
Net Cash Per Share	-0.02
Equity (Book Value)	505.67M
Book Value Per Share	0.24
Working Capital	-35.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.70 million and capital expenditures -20.61 million, giving a free cash flow of -30.30 million.

Operating Cash Flow	-9.70M
Capital Expenditures	-20.61M
Free Cash Flow	-30.30M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 46.08%, with operating and profit margins of -16.41% and -18.60%.

Gross Margin	46.08%
Operating Margin	-16.41%
Pretax Margin	-16.47%
Profit Margin	-18.60%
EBITDA Margin	-7.42%
EBIT Margin	-16.41%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 3.47%.

Dividend Per Share	0.01
Dividend Yield	3.47%
Dividend Growth (YoY)	-51.85%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.47%
Earnings Yield	-19.03%
FCF Yield	-9.40%

Dividend Details

Stock Splits

The last stock split was on September 2, 1999. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 2, 1999
Split Type	Forward
Split Ratio	1.5

Scores

HKG:0455 has an Altman Z-Score of 1.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.33
Piotroski F-Score	n/a